CCSG - Hepatocellular Carcinoma

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. Pancreatic Neoplasms 99%
3. Neoplasms 65%
4. Liver 58%
5. Chromatin 42%
6. Confidence Intervals 39%
7. Survival 37%
8. Odds Ratio 36%
9. Genes 33%
10. Case-Control Studies 32%
11. Neoplasm Metastasis 27%
12. Liver Transplantation 27%
13. Genotype 24%
14. Neuroendocrine Tumors 22%
15. Liver Neoplasms 20%
16. Radiologists 19%
17. Histones 18%
18. Genome-Wide Association Study 18%
19. Fetal Proteins 17%
20. Pathology 17%
21. Hepacivirus 16%
22. Cholangiocarcinoma 16%
23. Gene Expression 15%
24. Lysine 15%
25. Smoking 15%
26. Tomography 15%
27. alpha-Fetoproteins 15%
28. Fibrolamellar hepatocellular carcinoma 15%
29. DNA 14%
30. Carcinoid Tumor 14%
31. Therapeutics 14%
32. Single Nucleotide Polymorphism 13%
33. Liver Regeneration 13%
34. Data Systems 13%
35. Smokers 13%
36. Magnetic Resonance Imaging 13%
37. Recurrence 12%
38. Logistic Models 12%
39. Somatomedins 12%
40. Pancreas 12%
41. Proteins 12%
42. Fibrosis 12%
43. Blood Vessels 11%
44. Drug Therapy 11%
45. Colorectal Neoplasms 11%
46. Transplants 11%
47. Hepatitis 11%
48. Differential Diagnosis 11%
49. Vascular Endothelial Growth Factor A 11%
50. Tumor Biomarkers 11%
51. Acetyltransferases 10%
52. Ubiquitin-Protein Ligases 10%
53. Melanoma 10%
54. Hematologic Neoplasms 10%
55. Hypoxia 9%
56. Mutagens 9%
57. Transcription Factors 9%
58. Embryonic Stem Cells 9%
59. Cytochromes 9%
60. Renal Cell Carcinoma 9%
61. Kidney 9%
62. Liver Diseases 9%
63. Transforming Growth Factors 9%
64. Fluorouracil 9%
65. Alleles 9%
66. Catenins 9%
67. Carcinoma 9%
68. Chromatin Immunoprecipitation 9%
69. DNA Damage 8%
70. DNA Adducts 8%
71. Mutation 8%
72. Survival Rate 8%
73. Adenocarcinoma 8%
74. Methylation 8%
75. Stomach 8%
76. Adrenocortical Carcinoma 8%
77. Bevacizumab 8%
78. Ganglioneuroma 8%
79. Alcohol Drinking 7%
80. Apoptosis 7%
81. Hydroxymethylglutaryl CoA Reductases 7%
82. Gallbladder 7%
83. Co-Repressor Proteins 7%
84. Allografts 7%
85. Breast Neoplasms 7%
86. Pheochromocytoma 7%
87. Metformin 7%
88. 3-hydroxy-3-methylglutaryl-coenzyme A 7%
89. Hepatectomy 7%
90. Epidemiology 7%
91. Population 7%
92. Hepatitis B virus 7%
93. Erlotinib Hydrochloride 7%
94. Spleen 7%
95. Mortality 7%
96. Thalidomide 7%
97. Cigarette Smoking 6%
98. Surgeons 6%
99. DNA Repair 6%
100. Morbidity 6%